sur SANOFI-AVENTIS (EPA:SAN)
Sanofi Releases Q1 2026 Aide-Mémoire to Support Financial Analysis
Sanofi, the R&D-driven biopharma company, announced the availability of its first quarter 2026 aide-mémoire on March 24, 2026. This tool is accessible via the "Investors" section on the company's website. It aims to facilitate financial modeling of the company's quarterly results by covering non-comparable items, foreign currency impact, and share count. The detailed financial results for Q1 2026 will be released on April 23, 2026.
Sanofi continues to focus on innovation and growth. The company combines its deep understanding of the immune system with advanced technology to develop medicines and vaccines. These efforts aim to meet urgent global healthcare challenges. Sanofi's strategic focus is supported by its commitment to stakeholder engagement and transparency.
R. H.
Copyright © 2026 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de SANOFI-AVENTIS